Law360, New York (October 16, 2008) -- Merck & Co. Inc. urged a district court judge on Thursday to sever a dozen cases from an expansive multidistrict litigation over the osteoporosis drug Fosamax, while the plaintiffs countered that the cases should be remanded to state court.
By severing a number of New Jersey plaintiffs from a group of almost 550 plaintiffs who originally sued in California state court, the U.S. District Court for the Southern District...
